NEW YORK, Feb 6 – Lexicon said Tuesday it has licensed its gene targeting technology to Immunex, bringing to 14 the number of its sublicensees.

Under the terms of the deal, Lexicon will receive annual license fees, technology usage frees for any model Immunex develops using the technology, as well as milestone payments for future discoveries.

Exact figures were not disclosed.

Lexicon of The Woodlands, Tex., determines gene function using large-scale knockout mouse technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.